Literature DB >> 7150458

Differences of sympathomimetic and anticholinergic action of OH-maprotiline and its R (-)-enantiomer.

O Schmidlin, U Gundert-Remy, W Mäurer, E Weber.   

Abstract

1 C 49802 B-Ba and CGP 12103/A are the racemate and the R (-)-enantiomer respectively of the hydroxylated derivative of the tetracyclic antidepressant maprotiline, which differed in their ability to block noradrenaline-uptake and in their anticholinergic activity in animal models. 2 The sympathomimetic and anticholinergic activities of both substances were evaluated in eight healthy subjects and compared with the treatment with placebo and amitriptyline. 3 Heart rate, pupillary diameter, stimulated salivary flow rate and blood pressure were measured over a 15 h period keeping a very strict protocol. Plasma catecholamine levels were determined. 4 Saliva production was diminished following the administration of C 49802 B-Ba, CGP 12103/A and amitriptyline. 5 A moderate, but significant increase in heart rate and mean arterial blood pressure in the recumbent position was observed when C 49802 B-Ba was given. 6 The results in man are in agreement with the different activities found in animal experiments. 7 It can be concluded that the S (+)-enantiomer which the racemate contains is more active than the R (-)-enantiomer as to the anticholinergic and the sympathomimetic property.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150458      PMCID: PMC1427552          DOI: 10.1111/j.1365-2125.1982.tb02039.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

Review 1.  A review of the cardiovascular effects and toxicity of tricyclic antidepressants.

Authors:  J W Jefferson
Journal:  Psychosom Med       Date:  1975 Mar-Apr       Impact factor: 4.312

2.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range.

Authors:  M Da Prada
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  Cardiovascular effects of tricyclic and tetracyclic antidepressants.

Authors:  D Burckhardt; E Raeder; V Müller; P Imhof; H Neubauer
Journal:  JAMA       Date:  1978-01-16       Impact factor: 56.272

Review 4.  Amine uptake inhibitors: criteria of selectivity.

Authors:  L Maître; P Moser; P A Baumann; P C Waldmeier
Journal:  Acta Psychiatr Scand Suppl       Date:  1980

5.  Tests of autonomic function in assessing centrally-acting drugs.

Authors:  P Turner
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

6.  The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers.

Authors:  E Szabadi; P Gaszner; C M Bradshaw
Journal:  Br J Psychiatry       Date:  1980-11       Impact factor: 9.319

7.  Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A.

Authors:  P C Waldmeier; P A Baumann; M Wilhelm; R Bernasconi; L Maître
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432

Review 8.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

9.  Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo.

Authors:  H Kopera
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

10.  Tricyclic antidepressants and peripheral anticholinergic activity.

Authors:  S E Arnold; R J Kahn; L L Faldetta; R A Laing; D M McNair
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  10 in total
  2 in total

1.  Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine.

Authors:  U Gundert-Remy; E Amann; R Hildebrandt; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Amitriptyline and oxaprotiline in the treatment of hospitalized depressive patients. Clinical aspects, psychophysiology, and drug plasma levels.

Authors:  H Giedke; H Gaertner; U Breyer-Pfaff; W Rein; D Axmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.